CCP
BIIB icon

Corient Capital Partners’s Biogen BIIB Stock Holding History

Corient Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$492K Buy
2,411
+452
+23% +$96K 0.04% 341
2022
Q2 		$400K Sell
1,959
-391
-17% -$79.9K 0.03% 398
2022
Q1 		$495K Buy
2,350
+593
+34% +$129K 0.03% 390
2021
Q4 		$421K Sell
1,757
-776
-31% -$200K 0.03% 407
2021
Q3 		$717K Sell
2,533
-411
-14% -$135K 0.05% 277
2021
Q2 		$1.02M Buy
2,944
+254
+9% +$76.9K 0.07% 211
2021
Q1 		$753K Buy
2,690
+360
+15% +$97.1K 0.06% 238
2020
Q4 		$570K Sell
2,330
-1,397
-37% -$360K 0.06% 253
2020
Q3 		$1.06M Sell
3,727
-58
-2% -$16.2K 0.12% 155
2020
Q2 		$1.01M Buy
3,785
+893
+31% +$268K 0.12% 155
2020
Q1 		$915K Buy
2,892
+176
+6% +$53.4K 0.14% 133
2019
Q4 		$806K Sell
2,716
-2,637
-49% -$732K 0.1% 204
2019
Q3 		$1.25M Buy
5,353
+3,367
+170% +$784K 0.18% 137
2019
Q2 		$465K Buy
1,986
+626
+46% +$145K 0.07% 248
2019
Q1 		$321K Buy
1,360
+153
+13% +$48.2K 0.05% 273
2018
Q4 		$363K Buy
1,207
+422
+54% +$135K 0.06% 239
2018
Q3 		$277K Hold
785
– – 0.05% 235
2018
Q2 		$228K Buy
+785
New +$221K 0.04% 247
2017
Q3 		– Sell
-935
Closed -$254K – 272
2017
Q2 		$254K Sell
935
-52
-5% -$13.8K 0.04% 275
2017
Q1 		$270K Buy
987
+70
+8% +$19.8K 0.04% 265
2016
Q4 		$260K Buy
+917
New +$272K 0.05% 269

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Corient Capital Partners's BIIB Position: Q3 2022 in Review

Corient Capital Partners increased its Biogen (BIIB) stake by 23% in Q3 2022, buying an estimated $96K and bringing the position to 2,411 shares worth $492K. The position accounts for 0.04% of the portfolio, ranked #341.

Corient Capital Partners first reported a position in BIIB in Q4 2016 and has held it in 21 quarters since. The position peaked at $1.25M in Q3 2019. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Corient Capital Partners held 2,411 shares of Biogen worth $492K as of Q3 2022.
  • Corient Capital Partners bought 452 Biogen shares in Q3 2022, an estimated $96K.
  • Biogen made up 0.04% of Corient Capital Partners's portfolio in Q3 2022, its #341 holding.
  • Corient Capital Partners first reported a position in Biogen in Q4 2016 and has held it in 21 quarters since.
  • Corient Capital Partners's Biogen position peaked at $1.25M in Q3 2019.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.